Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance
- PMID: 15670145
- DOI: 10.1111/j.1742-4658.2004.04476.x
Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance
Abstract
Transglutaminases form a large family of intracellular and extracellular enzymes that catalyse the Ca2+-dependent post-translational modification of proteins. Despite significant advances in our understanding of the biological role of most mammalian transglutaminase isoforms, recent findings suggest new scenarios, most notably for the ubiquitous tissue transglutaminase. It is becoming apparent that some transglutaminases, normally expressed at low levels in many tissue types, are activated and/or overexpressed in a variety of diseases, thereby resulting in enhanced concentrations of cross-linked proteins. As applies to all enzymes that exert their metabolic function by modifying the properties of target proteins, the identification and characterization of the modified proteins will cast light on the functions of transglutaminases and their involvement in human diseases. In this paper we review data on the properties of mammalian transglutaminases, particularly as regards their protein substrates and the relevance of transglutaminase-catalysed reactions in physiological and disease conditions.
Similar articles
-
Identification of protein substrates for transglutaminase in Caenorhabditis elegans.Biochem Biophys Res Commun. 2001 May 18;283(4):964-8. doi: 10.1006/bbrc.2001.4872. Biochem Biophys Res Commun. 2001. PMID: 11350079
-
Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases: minireview article.Amino Acids. 2004 Jul;26(4):431-4. doi: 10.1007/s00726-004-0089-1. Epub 2004 Apr 14. Amino Acids. 2004. PMID: 15290350 Review.
-
Transglutaminases and their substrates in biology and human diseases: 50 years of growing.Amino Acids. 2009 Apr;36(4):599-614. doi: 10.1007/s00726-008-0124-8. Epub 2008 Jul 3. Amino Acids. 2009. PMID: 18597041 Review.
-
Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.Adv Drug Deliv Rev. 2008 Jan 3;60(1):13-28. doi: 10.1016/j.addr.2007.06.015. Epub 2007 Aug 16. Adv Drug Deliv Rev. 2008. PMID: 17916398 Review.
-
Evidences for a role of protein cross-links in transglutaminase-related disease.Amino Acids. 2012 Feb;42(2-3):975-86. doi: 10.1007/s00726-011-1011-2. Epub 2011 Jul 29. Amino Acids. 2012. PMID: 21800260 Review.
Cited by
-
AGEomics Biomarkers and Machine Learning-Realizing the Potential of Protein Glycation in Clinical Diagnostics.Int J Mol Sci. 2022 Apr 21;23(9):4584. doi: 10.3390/ijms23094584. Int J Mol Sci. 2022. PMID: 35562975 Free PMC article. Review.
-
Transglutaminase regulation of cell function.Physiol Rev. 2014 Apr;94(2):383-417. doi: 10.1152/physrev.00019.2013. Physiol Rev. 2014. PMID: 24692352 Free PMC article. Review.
-
Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states.Cell Tissue Res. 2014 Dec;358(3):793-805. doi: 10.1007/s00441-014-1990-x. Epub 2014 Sep 11. Cell Tissue Res. 2014. PMID: 25209703 Free PMC article.
-
Cellular functions of tissue transglutaminase.Int Rev Cell Mol Biol. 2012;294:1-97. doi: 10.1016/B978-0-12-394305-7.00001-X. Int Rev Cell Mol Biol. 2012. PMID: 22364871 Free PMC article. Review.
-
The myofibroblast matrix: implications for tissue repair and fibrosis.J Pathol. 2013 Jan;229(2):298-309. doi: 10.1002/path.4104. J Pathol. 2013. PMID: 22996908 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous